- Consumer Products
- Latest 97.65
- Currency US$
- Change -0.42
- Percent Change -0.428 %
- Volume 896,195
- Thu Dec 5, 2013 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Oct 21||$0.40||Jan 27||$0.43|
12 months ended Dec 05, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.